MA53273A - Vésicules extracellulaires pour inhalation - Google Patents
Vésicules extracellulaires pour inhalationInfo
- Publication number
- MA53273A MA53273A MA053273A MA53273A MA53273A MA 53273 A MA53273 A MA 53273A MA 053273 A MA053273 A MA 053273A MA 53273 A MA53273 A MA 53273A MA 53273 A MA53273 A MA 53273A
- Authority
- MA
- Morocco
- Prior art keywords
- inhalation
- extracellular vesicles
- vesicles
- extracellular
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
- A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- A61K48/0075—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the delivery route, e.g. oral, subcutaneous
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- A61K48/0091—Purification or manufacturing processes for gene therapy compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5063—Compounds of unknown constitution, e.g. material from plants or animals
- A61K9/5068—Cell membranes or bacterial membranes enclosing drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M11/00—Sprayers or atomisers specially adapted for therapeutic purposes
- A61M11/005—Sprayers or atomisers specially adapted for therapeutic purposes using ultrasonics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16041—Use of virus, viral particle or viral elements as a vector
- C12N2740/16043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- Dispersion Chemistry (AREA)
- Biophysics (AREA)
- Biomedical Technology (AREA)
- Pulmonology (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Manufacturing & Machinery (AREA)
- Otolaryngology (AREA)
- Cell Biology (AREA)
- Virology (AREA)
- Botany (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Biochemistry (AREA)
- Hematology (AREA)
- Heart & Thoracic Surgery (AREA)
- Anesthesiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP18188591 | 2018-08-10 | ||
| EP19154302 | 2019-01-29 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA53273A true MA53273A (fr) | 2021-06-16 |
Family
ID=67766129
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA053273A MA53273A (fr) | 2018-08-10 | 2019-08-09 | Vésicules extracellulaires pour inhalation |
Country Status (15)
| Country | Link |
|---|---|
| US (2) | US12029821B2 (fr) |
| EP (1) | EP3833331A1 (fr) |
| JP (1) | JP7480143B2 (fr) |
| KR (1) | KR102875565B1 (fr) |
| CN (1) | CN112566626A (fr) |
| AU (1) | AU2019316742B2 (fr) |
| BR (1) | BR112021002286A2 (fr) |
| CA (1) | CA3108605A1 (fr) |
| CL (1) | CL2021000334A1 (fr) |
| IL (1) | IL280658B2 (fr) |
| MA (1) | MA53273A (fr) |
| MX (1) | MX2021001574A (fr) |
| SG (1) | SG11202100870UA (fr) |
| WO (1) | WO2020030817A1 (fr) |
| ZA (1) | ZA202100886B (fr) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2020030817A1 (fr) * | 2018-08-10 | 2020-02-13 | Omnispirant Limited | Vésicules extracellulaires pour inhalation |
| CN113384597A (zh) * | 2020-03-13 | 2021-09-14 | 西比曼生物科技(上海)有限公司 | 含人体细胞衍生的细胞膜外囊泡的雾化吸入制剂、制法及其应用 |
| CN111500607B (zh) * | 2020-03-13 | 2022-05-03 | 首都医科大学附属北京口腔医院 | 种植体周围抗炎用融合基因、外泌体、生物涂料以及制备方法和应用 |
| EP4122475A4 (fr) * | 2020-03-16 | 2024-07-03 | Exostemtech Co., Ltd. | Nouvelle utilisation d'un dispositif de filtration à flux tangentiel pour préparer un exosome fonctionnel |
| WO2021207126A1 (fr) * | 2020-04-06 | 2021-10-14 | The Trustees Of Dartmouth College | Compositions et méthodes de traitement d'infections bactériennes |
| CN113244173A (zh) * | 2021-04-06 | 2021-08-13 | 浙江大学医学院附属邵逸夫医院 | 一种间充质干细胞外泌体改性修饰囊泡及其制备方法 |
| CN115212230B (zh) * | 2021-04-21 | 2024-12-27 | 时比曼生物科技(上海)有限公司 | 含有干细胞胞外囊泡的药物组合物及其在呼吸道炎症治疗中的应用 |
| CN113522384A (zh) * | 2021-07-06 | 2021-10-22 | 温州医科大学附属眼视光医院 | 一种微流控芯片及其制备与应用 |
| CN114480260B (zh) * | 2022-01-24 | 2024-02-09 | 同济大学 | 一种成体肺干细胞外泌体及其制备方法和应用 |
| CN115181724A (zh) * | 2022-06-10 | 2022-10-14 | 浙江工业大学 | 一种间充质干细胞来源的外泌体及其制备方法与应用 |
| WO2024143644A1 (fr) * | 2022-12-30 | 2024-07-04 | 한국과학기술연구원 | Vésicules extracellulaires dérivées de plantes modifiées en surface et système d'administration de médicament ciblée l'utilisant |
| CN116622608A (zh) * | 2023-05-31 | 2023-08-22 | 华中科技大学 | 一种诱导自裂解型抗抑郁工程菌株及其应用 |
| TWI925442B (zh) * | 2024-01-08 | 2026-05-11 | 大陸商亦及之洲生物科技(蘇州)有限公司 | 用於治療脫髮和/或白髮的工程化外泌體及其組合物和用途 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102063069B1 (ko) * | 2011-03-11 | 2020-01-08 | 칠드런'즈 메디컬 센터 코포레이션 | 중간엽 줄기 세포 엑소솜에 관련된 방법 및 조성물 |
| US20150018227A1 (en) * | 2011-08-05 | 2015-01-15 | University Of Louisville Research Foundation, Inc. | Microrna biomarkers |
| EP3470073A1 (fr) | 2012-04-03 | 2019-04-17 | Reneuron Limited | Microparicules de cellules souches |
| WO2014022852A1 (fr) * | 2012-08-03 | 2014-02-06 | Aptamir Therapeutics, Inc. | Administration cellulaire spécifique de modulateurs de miarn pour le traitement de l'obésité et de troubles associés |
| JP6137894B2 (ja) * | 2013-03-22 | 2017-05-31 | 国立大学法人京都大学 | リポソーム−エキソソームハイブリッドベシクル及びその調製法 |
| WO2015002956A1 (fr) | 2013-07-01 | 2015-01-08 | Ohio State Innovation Foundation | Système de distribution d'exosome |
| EA201890006A1 (ru) * | 2015-06-10 | 2018-05-31 | Борд Оф Риджентс, Дзе Юниверсити Оф Техас Систем | Применение экзосом для лечения болезни |
| WO2017075708A1 (fr) | 2015-11-05 | 2017-05-11 | Exerkine Corporation | Exosomes utiles pour traiter la fibrose kystique (cf) |
| KR20190100174A (ko) * | 2016-12-23 | 2019-08-28 | 엑소팜 리미티드 | 미세소포 및 엑소좀의 정제 또는 단리를 위한 방법 및 조성물 |
| CN107625727B (zh) * | 2017-08-10 | 2020-01-10 | 中国人民解放军第三O二医院 | 一种地塞米松纳米脂质体的胶体水溶液及其制备方法和应用 |
| WO2020030817A1 (fr) * | 2018-08-10 | 2020-02-13 | Omnispirant Limited | Vésicules extracellulaires pour inhalation |
-
2019
- 2019-08-09 WO PCT/EP2019/071511 patent/WO2020030817A1/fr not_active Ceased
- 2019-08-09 EP EP19758918.7A patent/EP3833331A1/fr active Pending
- 2019-08-09 AU AU2019316742A patent/AU2019316742B2/en active Active
- 2019-08-09 JP JP2021531194A patent/JP7480143B2/ja active Active
- 2019-08-09 CN CN201980053919.8A patent/CN112566626A/zh active Pending
- 2019-08-09 SG SG11202100870UA patent/SG11202100870UA/en unknown
- 2019-08-09 CA CA3108605A patent/CA3108605A1/fr active Pending
- 2019-08-09 KR KR1020217006920A patent/KR102875565B1/ko active Active
- 2019-08-09 US US17/267,158 patent/US12029821B2/en active Active
- 2019-08-09 IL IL280658A patent/IL280658B2/en unknown
- 2019-08-09 MX MX2021001574A patent/MX2021001574A/es unknown
- 2019-08-09 MA MA053273A patent/MA53273A/fr unknown
- 2019-08-09 BR BR112021002286-4A patent/BR112021002286A2/pt unknown
-
2021
- 2021-02-08 CL CL2021000334A patent/CL2021000334A1/es unknown
- 2021-02-09 ZA ZA2021/00886A patent/ZA202100886B/en unknown
-
2024
- 2024-05-23 US US18/672,495 patent/US20240315980A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| JP7480143B2 (ja) | 2024-05-09 |
| AU2019316742B2 (en) | 2024-11-14 |
| WO2020030817A1 (fr) | 2020-02-13 |
| IL280658B1 (en) | 2026-01-01 |
| IL280658B2 (en) | 2026-05-01 |
| US20240315980A1 (en) | 2024-09-26 |
| BR112021002286A2 (pt) | 2021-05-04 |
| SG11202100870UA (en) | 2021-02-25 |
| KR102875565B1 (ko) | 2025-10-23 |
| CL2021000334A1 (es) | 2021-06-18 |
| CN112566626A (zh) | 2021-03-26 |
| EP3833331A1 (fr) | 2021-06-16 |
| US20210308067A1 (en) | 2021-10-07 |
| MX2021001574A (es) | 2021-07-15 |
| KR20210042351A (ko) | 2021-04-19 |
| NZ772069A (en) | 2025-08-29 |
| US12029821B2 (en) | 2024-07-09 |
| AU2019316742A1 (en) | 2021-02-11 |
| JP2021534237A (ja) | 2021-12-09 |
| CA3108605A1 (fr) | 2020-02-13 |
| IL280658A (en) | 2021-03-25 |
| ZA202100886B (en) | 2025-05-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL280658A (en) | Extracellular vesicles for inhalation | |
| IL277344A (en) | Extracellular vesicles containing agonist-STING | |
| EP4009989A4 (fr) | Vésicules extracellulaires thérapeutiques | |
| IL286556A (en) | Extracellular vesicles for vaccine delivery | |
| EP3727351A4 (fr) | Vésicules extracellulaires modifiées pour une administration tissulaire améliorée | |
| EP3661556A4 (fr) | Vésicules extracellulaires synthétiques pour nouvelles thérapies | |
| EP3852770A4 (fr) | Vésicules extracellulaires modifiées en surface | |
| MA50087A (fr) | Vésicules extracellulaires provenant de prevotella | |
| MA50086A (fr) | Vésicules extracellulaires (ev) bactériennes | |
| EP3630078A4 (fr) | Agents pour chimio-embolisation | |
| EP3426261A4 (fr) | Ligands de ciblage pour composés thérapeutiques | |
| HUE051792T2 (hu) | Humán vérlemezke lizátumból származó extracelluláris vezikulák gyógyászatban való alkalmazásra | |
| EP3423044A4 (fr) | Nanovaccin activant sting pour l'immunothérapie | |
| EP3393911A4 (fr) | Station d'accueil autonome pour drones | |
| EP3430024A4 (fr) | Vésicules membranaires thérapeutiques | |
| EP3525735A4 (fr) | Ultrasons thérapeutiques pour troubles oculaires | |
| EP3344295A4 (fr) | Récepteurs d'antigène chimère tn anti-sialyle | |
| EP3250706A4 (fr) | Vésicules extracellulaires pour l'administration d'un agent | |
| IT201900024580A1 (it) | Vescicole extracellulari da microalghe | |
| EP3380177A4 (fr) | Bronchoscope pour voies respiratoires | |
| IL280851A (en) | Targeted extracellular vesicles | |
| EP3445428A4 (fr) | Dispositif d'espacement pour inhalateur | |
| EP3704341A4 (fr) | Latte pour volet roulant | |
| EP3307268A4 (fr) | Phenyl-oxazolidinones substituées pour la thérapie antimicrobienne | |
| EP3730141A4 (fr) | Agent thérapeutique pour la pollakiurie nocturne |